Navigation Links
DIA to Host 10th Middle East Regulatory Conference
Date:9/10/2013

Muscat, Sultanate of Oman (PRWEB) September 10, 2013

DIA will host its 10th Middle East Regulatory Conference (MERC) from Sept. 24 to 25 at Shangri-La’s Barr Al Jissah Resort and Spa Al Bandar hotel in Muscat 113, Sultanate of Oman. The two-day event will bring together the Middle East Regulatory Network (MERN), an ad hoc regional network of the European Federation of Pharmaceutical Industries and Associations. The MERN works in partnership with regulatory authorities and the pharmaceutical industry in the Middle East to develop legislation and regulatory practices that enable patients to access high-quality medicines, including innovative products.

“We’re excited to provide this two-day event, which will offer invaluable information and knowledge to every attendee,” said Jytte Lyngvig, director of DIA Europe. “This meeting brings together thought leaders from across the globe who will provide timely and valuable information to key stakeholders in the region—including representatives from ministries of health, local and multinational pharmaceutical companies—who will meet to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies.”

MERC 2013 sessions include:

  • Review Practices: Efficiencies & Timelines—Improving the registration process and reviewing the timelines of pharmaceutical and biological products.
  • Regulatory/Industry Panel Interactive Session—Discussing challenges with a combined authority and industry panel to improve access to innovative medicine for patients.
  • Pharmacovigilance: Monitoring and Evaluating the Safety Profile of Medicinal Products—Sharing recent developments in the European Union (EU), World Health Organization and Middle Eastern region as well as falsified medicines.
  • The Concept of Biotech Medicine and Biosimilars—Updating biosimilar requirements and assessments.
  • Global Health Economics and Market Access—Discussing faster and better accessibility to medicines for patients.
  • Regulatory Life Cycle Management—Optimizing maintenance and product compliance.
  • Regulatory Data Exclusivity and Patents—Educating stakeholders on the data protection landscape in the Middle East and what remains to be done.
  • Code of Ethics and Promotion—Discussing the implementation in the EU and Middle Eastern regions and sharing regulators’ and the industry’s perspectives.

Ministry of Health speakers include:

  • Professor Saleh A. Bawazir, vice president of drug affairs, Saudi Food and Drug Authority, Kingdom of Saudi Arabia
  • Dr. Bahaa Eldin Fateha, chief executive, National Health Regulatory Authority, Kingdom of Bahrain
  • Mr. Thomas Heynisch, deputy head of unit, Food and Healthcare Industries, Biotechnology, European Commission, Belgium
  • Dr. Hayel Mohamad Obeidat, director general, Jordan Food and Drug Administration, Jordan
  • Dr. Colette Raidy, head, Pharmaceutical Inspection Department, Ministry of Public Health, Lebanon
  • Dr. Shahrokh Veisi, Biologics Department, Food and Drug Organization of Ministry of Health, Iran
  • Dr. Christa Wirthumer-Hoche, member, CMDh, and deputy head, Austrian Medicines and Medical Devices Agency, Austria

To find out more about the event and to register, visit the website for DIA’s 10th MERC.

ABOUT DIA: DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C.; and Latin America. Visit our website at http://www.diahome.org and follow DIA at: LinkedIn, Twitter, YouTube, Facebook, Flickr and Pinterest.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11108058.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
2. Study: More Pre-Teens Get Vaccines When Middle Schools Require Them
3. Fitness in Middle Age Lowers Medical Costs Later: Study
4. Middle-Aged Diabetics May Need Earlier Colon Checks
5. Lung cancer death rates among young and middle-aged white women climb in some states
6. Childhood Abuse Linked to Diabetes, Heart Disease in Middle-Aged Women
7. More Evidence That Exercise in Middle Age Boosts Health
8. Obesity in Middle Age Tied to More Rapid Mental Decline: Study
9. Sport makes middle-aged people smarter
10. Higher Blood Pressure May Harm the Middle-Aged Brain, Study Finds
11. Middle Age Can Be a Bummer for Great Apes, Too
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi and ... who do not do their research and undergo cosmetic dermatology treatments from unqualified practitioners ... of a renaissance and every other month a new treatment or device is launched, ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... called the CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial ... healthcare settings. , Over the last 60 years, studies have shown that ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... innovative, personalized cell-based treatment for a high-risk form of the most common ... Hospital of Philadelphia today reported new results using ... The physician-scientists presented findings at the annual meeting of the American ... Continue Reading ... ...
(Date:12/2/2016)... , Dec 2, 2016 Research and Markets ... newsletter to their offering. ... , , R&D Drug ... Publishing,s proprietary R&D Drug Pipeline Database provides 24/7 online access to ... on the market and on investigational drug candidates in research & ...
(Date:12/2/2016)... Columbia , December 2, 2016 - bioLytical lanza el ... nuevas directrices de la OMS     Continue Reading ... ... , , ... enfermedades infecciosas, ha anunciado hoy que está expandiendo el lanzamiento de su INSTI ...
Breaking Medicine Technology: